Search

everythinglearnresearchcommunity

for

Search:↓

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

A man's scalp infection, mistaken for bacterial, was actually a rare fungal infection treated successfully with antifungal medication.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The document says that there are treatments for hair and nail diseases.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

More research is needed to understand hair and scalp disorders in people with skin of color.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Clascoterone is safe for the heart, even at high doses.

TrichoScan effectively diagnoses different types of hair loss and is linked to low iron stores in patients.

People with alopecia areata often have thyroid autoimmunity.

Exosomes could revolutionize skin disease treatment and healing.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Finasteride may increase stroke risk in people with clotting tendencies.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Patients with lichen planopilaris have a higher risk of heart disease.